Opportunity Information: Apply for MP MPC 11 001
Apply for MP MPC 11 001
- The Office of the Assistant Secretary for Health in the health sector is offering a public funding opportunity titled "FY11 Eliminating Lupus Health Disparities Initiative (ELHDI)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.004 Cooperative Agreements to Improve the Health Status of Minority Populations.
- This funding opportunity was created on May 13, 2011 and posted on May 13, 2011.
- Applicants must submit their applications by Jun 14, 2011 Refer to the grant announcement regarding application submission requirements, dates and times.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- To qualify for funding an applicant must be a national, non profit medical education society or allied health professional association, and a national leader in medical, nursing, and/or allied health education with a proven track record of working with other medical, related professional associations. be a professional organization composed of medical professionals and non physician health care professionals specializing in rheumatology, such as advanced practice nurses, nurses, occupational therapists, physical therapists, psychologists, social workers, epidemiologists, physician assistants educators, clinicians and researchers. demonstrate a reputation for leading medical health, nursing, or allied health professional consortiums or collaborative partnerships that at a minimum include schools of medicine, nursing, or allied health, medical, nursing, or allied health professional associations and scientific researchers and educators with knowledge and expertise in the epidemiology, treatment, and management of lupus. have a minimum of five years experience in professional training and education particularly with a focus in rheumatology and excellent knowledge and understanding of lupus. Have an established record of developing, disseminating, and delivering professional education to medical, nursing, and allied health professionals in a variety of settings (e.g., national meetings, medical schools, academic medical centers, and medical professional associations) and modalities (e.g., print, in person, on line, webinars, DVD, and other distance based learning). Non profit medical societies, medical, nursing, and allied health professional associations were identified as potential applicants because they are uniquely positioned and qualified to develop partnerships with medical schools and with other medical and nursing professional associations needed to disseminate and conduct education and training.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY11 Eliminating Lupus Health Disparities Initiative (ELHDI) was a federal discretionary grant opportunity offered by the Office of the Assistant Secretary for Health to address persistent lupus-related health disparities, especially those affecting racial and ethnic minority populations. The core goal was to improve how lupus is recognized and managed by strengthening education and training for both students in the health professions pipeline and clinicians already in practice. In practical terms, the initiative focused on improving early diagnosis, appropriate treatment, long-term management, and awareness of lupus-related impacts on overall health and quality of life, with the expectation that better-prepared health professionals would help reduce gaps in outcomes across different populations.
The project was structured as a cooperative agreement, signaling that the awardee would work closely with the federal agency rather than operating entirely independently. The program planned to fund a single national entity, making this a centralized, nationwide effort rather than multiple smaller awards. The award amount was fixed, with an award floor and ceiling of $1,000,000, and there was no cost sharing or matching requirement. The opportunity was posted May 13, 2011, with an application deadline of June 14, 2011, and it was later archived July 14, 2011. The CFDA listing associated with the program was 93.004, titled Cooperative Agreements to Improve the Health Status of Minority Populations, placing the initiative within a broader federal strategy aimed at improving minority health outcomes.
The funded organization was expected to serve as the central developer and distributor of lupus education content. Its responsibilities included developing, testing, and disseminating curricula, curriculum components, training tools, and related resources focused on lupus. The initiative emphasized adoption within schools that train future clinicians, so the awardee also had to identify and recruit a range of medical, nursing, and allied health professions schools to participate, and then work with partners to encourage real curriculum change and use of the ELHDI materials. In addition, the awardee had to maintain a lupus consortium, essentially a structured group of experts and stakeholders used to guide, inform, and strengthen the program’s direction and products.
A major theme of the ELHDI design was that improving education in professional schools alone would not be enough to meet the disparities goal. For that reason, the program also required robust outreach to practicing health care professionals, using multiple dissemination strategies such as live meetings, online sessions, webinars, and satellite conferences. The intended audience extended across the clinical team, targeting physicians, physician assistants, nurse practitioners, nurses, and other allied health professionals who might encounter patients with lupus and influence the timeliness and quality of care. By emphasizing both pre-service training (students) and in-service continuing education (practicing professionals), the initiative aimed to increase clinical suspicion for lupus when symptoms present, support earlier referral and diagnosis, and promote evidence-informed management that reflects the needs and experiences of minority communities disproportionately affected by poor outcomes.
Eligibility was narrowly defined, reflecting the expectation that the awardee would already have the reach, credibility, and infrastructure to influence national education and training. Applicants had to be nonprofit organizations with 501(c)(3) status (excluding institutions of higher education) and specifically needed to be a national nonprofit medical education society or allied health professional association recognized as a leader in medical, nursing, and/or allied health education. The eligible organization was expected to have a proven track record working with other professional associations and to be composed of both medical professionals and non-physician health care professionals specializing in rheumatology, including roles such as advanced practice nurses, nurses, occupational therapists, physical therapists, psychologists, social workers, epidemiologists, physician assistants, educators, clinicians, and researchers. Beyond membership composition, applicants needed to demonstrate experience leading consortiums or collaborative partnerships that included professional schools (medicine, nursing, allied health), professional associations, and scientific researchers and educators with expertise in lupus epidemiology, treatment, and management. The opportunity also required at least five years of experience in professional training and education with a rheumatology focus and strong demonstrated capacity to develop and deliver education across settings (national meetings, medical schools, academic medical centers, professional associations) and modalities (print, in-person, online, webinars, DVD, and other distance-learning formats).
Overall, ELHDI was designed as a single-award, national-scale education and dissemination initiative meant to change how lupus is taught and how clinicians learn about it throughout their careers. By combining curriculum development, school recruitment and adoption efforts, partnership-driven dissemination, and a standing expert consortium, the program aimed to create practical, widely used training resources that could improve early recognition and high-quality management of lupus, ultimately helping reduce disparities in outcomes for minority populations.
FY11 Eliminating Lupus Health Disparities Initiative (ELHDI) - FAQs
What is the FY11 Eliminating Lupus Health Disparities Initiative (ELHDI)?
ELHDI was a federal discretionary grant opportunity offered by the Office of the Assistant Secretary for Health. It was designed to address persistent lupus-related health disparities, with a particular focus on disparities affecting racial and ethnic minority populations.
What was the main goal of ELHDI?
The core goal was to improve how lupus is recognized and managed by strengthening education and training for both (1) students in the health professions pipeline and (2) clinicians already in practice. The broader intent was that better-prepared health professionals would help reduce gaps in outcomes across different populations.
What lupus-related outcomes or improvements did the initiative aim to influence?
The initiative emphasized improving early diagnosis, appropriate treatment, long-term management, and awareness of lupus-related impacts on overall health and quality of life. It also aimed to increase clinical suspicion for lupus when symptoms present and to support earlier referral and diagnosis.
Which federal program listing (CFDA) was associated with ELHDI?
The opportunity was associated with CFDA 93.004, titled "Cooperative Agreements to Improve the Health Status of Minority Populations."
What type of award mechanism was used?
ELHDI was structured as a cooperative agreement, meaning the awardee was expected to work closely with the federal agency rather than operating entirely independently.
How many awards were planned under this opportunity?
The program planned to fund a single national entity, making it a centralized, nationwide effort rather than multiple smaller awards.
How much funding was available?
The award amount was fixed, with both the award floor and ceiling listed as $1,000,000.
Was cost sharing or a match required?
No. There was no cost sharing or matching requirement stated for this opportunity.
When was the opportunity posted, when were applications due, and when was it archived?
The opportunity was posted on May 13, 2011. The application deadline was June 14, 2011. It was later archived on July 14, 2011.
Who was eligible to apply?
Eligibility was narrowly defined. Applicants had to be nonprofit organizations with 501(c)(3) status (excluding institutions of higher education). The applicant also needed to be a national nonprofit medical education society or allied health professional association recognized as a leader in medical, nursing, and/or allied health education.
Were institutions of higher education eligible?
No. The eligibility description explicitly excluded institutions of higher education.
What kinds of organizations did ELHDI expect to lead the project?
The initiative expected a national organization with reach, credibility, and infrastructure to influence education and training nationwide, including the ability to work across professional schools, professional associations, and expert communities connected to rheumatology and lupus.
What membership composition or professional representation was expected of an eligible organization?
The eligible organization was expected to be composed of both medical professionals and non-physician health care professionals specializing in rheumatology. Examples listed included advanced practice nurses, nurses, occupational therapists, physical therapists, psychologists, social workers, epidemiologists, physician assistants, educators, clinicians, and researchers.
What prior experience was required for applicants?
Applicants needed to demonstrate experience leading consortiums or collaborative partnerships involving professional schools (medicine, nursing, allied health), professional associations, and scientific researchers/educators with lupus expertise. The opportunity also required at least five years of experience in professional training and education with a rheumatology focus, plus strong capacity to develop and deliver education across multiple settings and modalities.
What were the key responsibilities of the funded organization?
The funded organization was expected to function as the central developer and distributor of lupus education content. Responsibilities included developing, testing, and disseminating curricula, curriculum components, training tools, and related lupus-focused resources.
What kinds of educational products and materials were expected?
Expected products included curricula, curriculum components, training tools, and related resources focused on lupus, developed and tested and then broadly disseminated.
Did the initiative focus only on students in professional schools?
No. ELHDI emphasized that education in professional schools alone would not be sufficient to meet the disparities goal. In addition to student-focused curriculum efforts, the program required robust outreach to practicing health care professionals through multiple dissemination strategies.
What role did professional schools play in ELHDI?
The awardee had to identify and recruit a range of medical, nursing, and allied health professions schools to participate and work with partners to encourage real curriculum change and adoption of ELHDI materials within those schools.
What did "curriculum change and adoption" mean in this context?
Based on the opportunity description, it meant moving beyond simply creating materials to actively encouraging schools that train future clinicians to incorporate and use ELHDI lupus education content in their educational programs.
What is the lupus consortium referenced in the opportunity?
The funded organization was required to maintain a lupus consortium, described as a structured group of experts and stakeholders intended to guide, inform, and strengthen the program's direction and its educational products.
Who was the intended audience for the training and dissemination activities?
The intended audience included both students and practicing clinicians across the clinical team. The opportunity specifically targeted physicians, physician assistants, nurse practitioners, nurses, and other allied health professionals who might encounter patients with lupus and influence timeliness and quality of care.
What dissemination strategies were expected for reaching practicing clinicians?
The opportunity described multiple strategies such as live meetings, online sessions, webinars, and satellite conferences. It also noted a demonstrated capacity to deliver education through print, in-person training, online formats, webinars, DVD, and other distance-learning formats.
What settings were applicants expected to be able to deliver education in?
The opportunity expected strong capacity to develop and deliver education across settings such as national meetings, medical schools, academic medical centers, and professional associations.
Why was there an emphasis on minority health disparities?
ELHDI was specifically designed to address persistent lupus-related health disparities, especially those affecting racial and ethnic minority populations, with the expectation that improved education and training would help reduce differences in outcomes across populations.
How did ELHDI plan to reduce disparities in lupus outcomes?
The initiative linked disparities reduction to better education and training: increasing clinician readiness to recognize lupus earlier, supporting appropriate treatment and long-term management, and promoting evidence-informed care that reflects the needs and experiences of minority communities disproportionately affected by poor outcomes.
Was this opportunity local, regional, or national in scope?
It was national in scope. The program planned to fund a single national entity and positioned the awardee as the central developer and distributor of lupus education content across the country.
What did it mean that the funded organization would be the "central developer and distributor"?
It meant the funded organization would lead the creation, testing, and dissemination of ELHDI lupus education content and resources, and would be responsible for distributing those materials broadly to support adoption and training nationwide.
What kinds of partnerships or collaborations were expected?
Applicants were expected to have a track record working with other professional associations and to demonstrate experience leading consortiums or collaborative partnerships that include professional schools, professional associations, and lupus-focused scientific researchers and educators.
Was the initiative focused only on rheumatologists?
No. While the opportunity had a strong rheumatology focus, the dissemination and training were aimed across the broader clinical team, including physicians and non-physician health professionals who may encounter lupus patients and influence diagnosis, referral, and management.
Did the opportunity specify any required specialties or content focus areas?
The opportunity emphasized lupus epidemiology, treatment, and management, and required a rheumatology focus in professional training and education experience.
Browse more opportunities from the same category: Health
Next opportunity: Early Head Start Replacement Grantee Moca y San Sebastian, Puerto Rico
Previous opportunity: Early Head Start Replacement Grantee Zavala, Kinney, Real, Edward and Uvalde Counties, Texas
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for MP MPC 11 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (MP MPC 11 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Immunization Strengthening through Measles Control and Related Childhood Morbidity/Mortality Reduction from Vaccine Preventable Diseases Apply for CDC RFA IP11 1105 Funding Number: CDC RFA IP11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 11 001 Funding Number: CMS 1H0 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Apply for CMS 1I0 11 001 Funding Number: CMS 1I0 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| NIA Limited Competition Renewals of, and Revisions to, Existing Cooperative Agreement Awards (U01) Apply for PAR 11 213 Funding Number: PAR 11 213 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Multimedia project to promote child well being, early childhood development research, and violence prevention Apply for CDC RFA CE11 1105 Funding Number: CDC RFA CE11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Expanding HIV Training into Graduate Medical Education Apply for HRSA 11 171 Funding Number: HRSA 11 171 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Blood Safety Surveillance among People with Blood Disorders Apply for CDC RFA DD11 1108 Funding Number: CDC RFA DD11 1108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| NIDCD Research On Hearing Health Care (R21/R33) Apply for RFA DC 12 003 Funding Number: RFA DC 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Professionals Apply for CDC RFA DD11 1105 Funding Number: CDC RFA DD11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Addressing Immunization Disparities in Minority Populations Apply for CDC RFA IP11 1101 Funding Number: CDC RFA IP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Capacity Building Assistance (CBA) To Improve The Delivery And Effectiveness Of Human Immunodeficiency Virus (HIV) Prevention Services For High Risk And/Or Racial/Ethnic Minority Populations Apply for CDC RFA PS09 9060201SUPP11 Funding Number: CDC RFA PS09 9060201SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $103,550 |
| Systems for Improved Access to Pharmaceuticals and Services Apply for SOL OAA 11 000064 Funding Number: SOL OAA 11 000064 Agency: Agency for International Development Category: Health Funding Amount: $198,000,000 |
| FY11 OAH National Resource Center for HIV/AIDS Prevention among Adolescents Apply for AH TP2 11 001 Funding Number: AH TP2 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $200,000 |
| Technology Development for High Throughput Functional Genomics (R21) Apply for RFA HG 11 014 Funding Number: RFA HG 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R01) Apply for RFA HG 11 013 Funding Number: RFA HG 11 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R43/44) Apply for RFA HG 11 015 Funding Number: RFA HG 11 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| ORAL HEALTH TRAINING AND TECHNICAL ASSISTANCE NATIONAL COOPERATIVE AGREEMENT Apply for HRSA 11 180 Funding Number: HRSA 11 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN)(R21) Apply for PA 11 217 Funding Number: PA 11 217 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN) (R01) Apply for PA 11 218 Funding Number: PA 11 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predictive Biodosimetry Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries (R01) Apply for RFA AI 11 033 Funding Number: RFA AI 11 033 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "MP MPC 11 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.